Rotational atherectomy is only an interim strategy.

Original title: High-Speed Rotational Atherectomy Before Paclitaxel-Eluting Stent Implantation in Complex Calcified Coronary Lesions. The Randomized ROTAXUS (Rotational Atherectomy Prior to Taxus Stent Treatment for Complex Native Coronary Artery Disease) Trial. Reference: Mohamed Abdel-Wahab et al. J Am Coll Cardiol Intv 2013; article in press

Heavily calcified lesions are difficult and may prevent the appropriate expansion of a drug-eluting stent (DES) with consequent increased risk of thrombosis and/or restenosis. 

Besides this type of injury may also damage the DES polymer and produce an inadequate diffusion of the drug to the subintimal. Rotational atherectomy, (RA), can effectively ablate these plates which could improve the effectiveness of a DES in this context. 

Rotablator was used (Boston Scientific Scimed, Maple Grove, Minnesota) with a chosen size of catheter to achieve a relationship with the size of the vessel 0.5. The primary endpoint was late lumen loss at nine months of angiographic follow-up. 240 patients were randomized with de novo lesions and moderate to severe calcification and Taxus versus rotational atherectomy and Taxus. 

The clinical and angiographic characteristics were well balanced between the groups. Making an analysis by treatment intention, angiographic success was identical, (96.7%), but considering that 12.5% of randomized patients to standard dilation finally received RA, the ultimate results achieved was significantly better for RA (92.5% versus 83.3%, P = 0.03). 

A 9 month follow-up of cardiac events (MACE) was similar in both groups, (24.2% versus standard. RA 28.3%, P = 0.46), as well as late lumen loss (primary endpoint) with 0.31 ± 0.52 mm versus standard group and 0.44 ± 0.58 mm for RA (p = 0.04).

Conclusion 

In this study routine rotational atherectomy prior to Taxus stent implantation in calcified lesions was not superior to Taxus stent implantation only.

Editorial Comment:

ROTAXUS is the first randomized, controlled trial testing routine rotational atherectomy prior to DES and probably evaluated a population with more complex anatomy which has been included in the job with stents. Considering the results, the high volume at centers and the great experience of the surgeons involved, we would say that the use of rotational atherectomy is just a rescue strategy. However, the “standard strategy” was to dilate to high atmospheres using not self-righteous balloons. Despite this, there was a high crossover. While it is true that rotational atherectomy does not improve performance in monitoring, it does change impatient procedure success in this type of injury.

SOLACI.ORG

More articles by this author

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

Rotational atherectomy and its technical secrets: use of floppy or ES guidewire

Rotational atherectomy (RA) remains a very useful tool in the management of severe coronary calcification. However, many of its technical aspects rely more on...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...